Health ❯ Clinical Research

Drug Trials

Patient Outcomes Animal Studies Mouse Models Antibiotic Efficacy Omalizumab Drug Trials Anti-Amyloid Therapies Cannabis Studies Phase 1 Trials Neurodevelopmental Disorders Regulatory Approval Adverse Effects GLP-1 Agonists Phase II Studies Efficacy Studies Polypill Studies Omalizumab (Xolair) Trials Laboratory Studies Adjuvant Therapy Human Studies Phase 3 Trials Participant Enrollment

Biogen, Dayra Launch $50 Million Pact to Develop Oral Macrocyclic Peptides for Immunology

The early-stage tie-up links Dayra’s macrocycle platform to Biogen’s development engine to expand its immunology pipeline.

Cannabis Extract VER-01 Eases Chronic Low Back Pain in Phase 3 Trial

Bristol Myers’ Iberdomide Combo Hits MRD Goal in Phase 3 Myeloma Study

Semaglutide Curbs Cocaine Use and Relapse-Seeking in Rats, Peer-Reviewed Study Finds

UCLA Study Finds Antidepressants Boost Immune Response Against Cancer